This may have directional significance for the new therapeutic modalities in the treatment of COVID-19 and allow us to further investigate the effects of UPR on FIP200-Beclin-1 axis activation and viral replication to combat the virus. This evidence concerns the gene RB1CC1 and COVID-19.